In Vitro Activity of the Ketolide ABT-773 |
| |
Authors: | Arthur L Barry Peter C Fuchs and Steven D Brown |
| |
Institution: | The Clinical Microbiology Institute, 9725 S.W. Commerce Circle, Wilsonville, OR 97070, USA. cmi@hevanet.com |
| |
Abstract: | The in vitro activities of ABT-773, azithromycin, erythromycin, and clindamycin were compared by testing 1,223 clinical isolates selected to represent different species and phenotypes. ABT-773 was particularly potent against staphylococci (the MIC at which 90% of the strains tested were inhibited MIC(90)] was < or =0.06 microg/ml), including all strains that were macrolide resistant but clindamycin susceptible. Streptococcus pneumoniae and other streptococci were inhibited by low concentrations of ABT-773, and that included most erythromycin-resistant strains. Against Haemophilus influenzae, ABT-773 and azithromycin were similar in their antibacterial potency (MIC(90), 4.0 and 2.0 microg/ml, respectively). |
| |
Keywords: | |
|
|